Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

What’s next for Top Glove shares?

The glove maker’s full-year revenue took a huge hit amid normalising demand in 2022.

Top glove share stock price target ratings sgx malaysia singapore Source: Bloomberg
  • Top Glove Corporation Bhd. (SGX: BVA) share price closed nearly 5% lower on Tuesday (20 September 2022)
  • The medical glove maker’s stock was down 15% in the last five sessions
  • It saw sales revenue decline 52% in the Q4 of 2022
  • Keen to trade Top Glove shares? Open an account with us to get started.

How did Top Glove fare in 2022?

Top Glove delivered a total sales revenue of 5.57 billion ringgit and profit after tax of 292 million ringgit for FY2022, equating to a decline of 66% and 96% respectively from FY2021.

For the fourth quarter (Q4) of FY2022, the glove manufacturing group posted a sales revenue amounting to 990 million ringgit (down 52% from Q4 FY2021), while posting a quarterly loss after tax of 42 million ringgit (down 109% from Q4 FY2021).

‘The glove industry is experiencing the effects of normalisation after delivering exceptionally high earnings over the past two years, due to the surge in demand for gloves and higher average selling prices (ASPs) during the pandemic,’ the group said of its performance.

The ‘softer performance’ also came as the ‘industry weathers an adjustment period, contending with the twin factors of oversupply coupled with excess stockpiling by customers during the pandemic,’ which has ‘led to a slowdown in orders’ and drop in ASPs.

Looking ahead, the group expects the business environment ‘to remain challenging’ into 2023, as customers continue to deplete pipeline inventories and glove demand/supply gradually equilibrates.

Top Glove stock price: what’s the latest forecast?

Top Glove shares are down by 73% in 2022, as demand for medical gloves began to normalise.

In terms of stock outlook, the latest analyst sentiments published by SGX StockFacts show a consensus rating of ‘underperform’, alongside a price target of S$0.33 on the stock.

The price target equates to a 57% upside potential from Top Glove’s last traded price of S$0.21.

UOB’s equity research team cut its price target from S$0.47 to S$0.30 while maintaining a ‘hold’ call following the group’s full-year results.

Analyst Philip Wong wrote that ‘the worst is yet to come’, as he expects earnings to decline further with demand-supply dynamics still ‘imbalanced’. However, he also noted that the ‘downside is increasingly limited with some producers already falling into losses’.

Thinking of trading Top Glove shares?

Go long or short via CFDs on Top Glove and other Singapore shares with our award-winning platform.* Open an account with us to start trading shares immediately.

*Awarded the Best Online Trading Platform by Influential Brands in 2021.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.